Masimo Net Profit Margin 2011-2025 | MASI
Current and historical net profit margin for Masimo (MASI) from 2011 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Masimo net profit margin for the three months ending June 30, 2025 was .
| Masimo Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $2.15B | $-0.46B | -21.36% |
| 2025-03-31 | $2.13B | $-0.50B | -23.27% |
| 2024-12-31 | $2.10B | $-0.31B | -14.56% |
| 2024-09-30 | $1.74B | $0.08B | 4.55% |
| 2024-06-30 | $1.71B | $0.08B | 4.67% |
| 2024-03-31 | $1.82B | $0.08B | 4.39% |
| 2023-12-31 | $2.05B | $0.08B | 4.00% |
| 2023-09-30 | $2.12B | $0.09B | 4.21% |
| 2023-06-30 | $2.19B | $0.12B | 5.31% |
| 2023-03-31 | $2.30B | $0.12B | 5.14% |
| 2022-12-31 | $2.04B | $0.14B | 7.08% |
| 2022-09-30 | $1.75B | $0.17B | 9.79% |
| 2022-06-30 | $1.50B | $0.19B | 12.70% |
| 2022-03-31 | $1.24B | $0.22B | 17.93% |
| 2021-12-31 | $1.24B | $0.23B | 18.48% |
| 2021-09-30 | $1.21B | $0.23B | 19.24% |
| 2021-06-30 | $1.18B | $0.22B | 18.95% |
| 2021-03-31 | $1.17B | $0.23B | 19.52% |
| 2020-12-31 | $1.14B | $0.24B | 20.98% |
| 2020-09-30 | $1.10B | $0.22B | 20.24% |
| 2020-06-30 | $1.05B | $0.22B | 21.18% |
| 2020-03-31 | $0.98B | $0.21B | 21.60% |
| 2019-12-31 | $0.94B | $0.20B | 20.87% |
| 2019-09-30 | $0.91B | $0.19B | 20.79% |
| 2019-06-30 | $0.90B | $0.20B | 22.10% |
| 2019-03-31 | $0.88B | $0.20B | 22.44% |
| 2018-12-31 | $0.86B | $0.19B | 22.58% |
| 2018-09-30 | $0.84B | $0.14B | 16.47% |
| 2018-06-30 | $0.83B | $0.12B | 14.29% |
| 2018-03-31 | $0.81B | $0.12B | 14.76% |
| 2017-12-31 | $0.79B | $0.13B | 15.82% |
| 2017-09-30 | $0.78B | $0.36B | 45.85% |
| 2017-06-30 | $0.76B | $0.35B | 46.31% |
| 2017-03-31 | $0.74B | $0.34B | 45.47% |
| 2016-12-31 | $0.71B | $0.31B | 43.76% |
| 2016-09-30 | $0.68B | $0.11B | 16.20% |
| 2016-06-30 | $0.66B | $0.10B | 15.21% |
| 2016-03-31 | $0.65B | $0.09B | 13.91% |
| 2015-12-31 | $0.63B | $0.08B | 13.15% |
| 2015-09-30 | $0.63B | $0.08B | 12.78% |
| 2015-06-30 | $0.62B | $0.08B | 12.32% |
| 2015-03-31 | $0.60B | $0.07B | 11.79% |
| 2014-12-31 | $0.59B | $0.07B | 12.44% |
| 2014-09-30 | $0.57B | $0.06B | 10.76% |
| 2014-06-30 | $0.55B | $0.06B | 11.19% |
| 2014-03-31 | $0.55B | $0.07B | 11.82% |
| 2013-12-31 | $0.55B | $0.06B | 10.62% |
| 2013-09-30 | $0.54B | $0.06B | 11.94% |
| 2013-06-30 | $0.52B | $0.06B | 11.83% |
| 2013-03-31 | $0.51B | $0.06B | 12.35% |
| 2012-12-31 | $0.49B | $0.06B | 12.78% |
| 2012-09-30 | $0.47B | $0.06B | 13.11% |
| 2012-06-30 | $0.46B | $0.06B | 13.76% |
| 2012-03-31 | $0.45B | $0.06B | 13.93% |
| 2011-12-31 | $0.44B | $0.06B | 14.58% |
| 2011-09-30 | $0.43B | $0.07B | 15.24% |
| 2011-06-30 | $0.43B | $0.07B | 15.58% |
| 2011-03-31 | $0.42B | $0.06B | 15.24% |
| 2010-12-31 | $0.41B | $0.07B | 17.98% |
| 2010-09-30 | $0.39B | $0.07B | 18.07% |
| 2010-06-30 | $0.38B | $0.07B | 17.94% |
| 2010-03-31 | $0.36B | $0.07B | 18.46% |
| 2009-12-31 | $0.35B | $0.05B | 15.19% |
| 2009-09-30 | $0.34B | $0.04B | 11.21% |
| 2009-06-30 | $0.33B | $0.04B | 11.52% |
| 2009-03-31 | $0.32B | $0.04B | 11.21% |
| 2008-12-31 | $0.31B | $0.03B | 10.42% |
| 2008-09-30 | $0.29B | $0.04B | 15.02% |
| 2008-06-30 | $0.28B | $0.04B | 13.62% |
| 2008-03-31 | $0.27B | $0.03B | 11.19% |
| 2007-12-31 | $0.26B | $0.02B | 8.98% |
| 2007-09-30 | $0.25B | $0.02B | 6.12% |
| 2007-06-30 | $0.24B | $0.01B | 5.06% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.117B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.83 |
| Intuitive Surgical (ISRG) | United States | $196.986B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.663B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |